RT @sitcancer: #JITC Research: PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory rec…
#JITC Research: PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors https://t.co/xCNZXzpqkv https://t.co/oW4b9DHzFw
RT @sitcancer: #JITC Research: PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory rec…
#JITC Research: PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors https://t.co/xCNZXzpqkv https://t.co/Sj7M4WJr4f
Pivotal study on PD-L1 blockade in enhancing anti tumor activity in TME
RT @sitcancer: #JITC Research: PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory rec…
RT @sitcancer: #JITC Research: PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory rec…
RT @sitcancer: #JITC Research: PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory rec…
RT @NFdeMiranda: Great (and lots of) work by @G_Beyrend. Congrats! https://t.co/phcsGUxzYn
RT @NFdeMiranda: Great (and lots of) work by @G_Beyrend. Congrats! https://t.co/phcsGUxzYn
Great (and lots of) work by @G_Beyrend. Congrats!
RT @MichaelodwyerMD: PD-L1 blockade increases number of TILs expressing both activating and inhibitory receptors. Dual blockade enhances t…
PD-L1 blockade increases number of TILs expressing both activating and inhibitory receptors. Dual blockade enhances tumor immunity.
#JITC Research: PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors https://t.co/xCNZXzpqkv https://t.co/MkHFOMn7Hd
RT @sitcancer: New #JITC Research: PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory…
PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors https://t.co/vB2TJ5q4Jt
RT @sitcancer: New #JITC Research: PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory…
New #JITC Research: PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors https://t.co/xCNZXzpqkv https://t.co/iOS5cqUtqf
An interesting paper showed that T cells in the tumor microenvironment may express both activating and inhibitory receptors. This T cell subset expands upon PD-L1 therapy https://t.co/By9iQ85ak2